On August 19, 2026, Hadassah University Medical Center in Ein Kerem, Jerusalem, announced that it had performed the world's first experimental treatment for brain cancer using a novel technology that emits highly bioefficient alpha particles. The procedure was carried out in collaboration with the Sharett Institute of Oncology, according to hospital officials.
The technology delivers concentrated radiation directly to tumor cells while sparing surrounding healthy tissue. This approach is considered a potential breakthrough for hard-to-treat brain cancers, such as glioblastoma, which have limited treatment options.
The patient, whose identity has not been disclosed, underwent the procedure as part of a clinical trial. Early results are not yet available, but the medical team expressed cautious optimism about the potential of this new therapy.
This marks a significant milestone in the field of radiation oncology, as alpha particle therapy has been studied for other cancers but never before applied to brain tumors. Further research and clinical trials will be needed to establish its safety and efficacy.
